[1] ALMUTAIRI K, NOSSENT J, PREEN D, et al. The global prevalence of rheumatoid arthritis: a meta-analysis based on a systematic review[J]. Rheumatol Int, 2021, 41(5): 863-877. [2] ZHANG Q, LIU Q, LIN C, et al. The prevalence of rheumatoid arthritis in middle-aged and elderly people living in Naqu City, Tibet, Autonomous Region of China[J]. J Orthop Surg Res, 2020, 15(1): 338. [3] JENNETTE J C, FALK R J. B cell-mediated pathogenesis of ANCA-mediated vasculitis[J]. Semin Immunopathol, 2014, 36(3): 327-338. [4] AFELTRA A, SEBASTIANI G D, GALEAZZI M, et al. Antineutrophil cytoplasmic antibodies in synovial fluid and in serum of patients with rheumatoid arthritis and other types of synovitis[J]. J Rheumatol, 1996, 23(1): 10-15. [5] MEKIC M, HADZIGRAHIC E, DZUBUR A. Relation between anti-CCP antibodies and sharp score in rheumatoid arthritis[J]. Mater Sociomed, 2020, 32(3): 172-176. [6] MULLER S, RADIC M. Citrullinated autoantigens: from diagnostic markers to pathogenetic mechanisms[J]. Clin Rev Allergy Immunol, 2015, 49(2): 232-239. [7] MEKIC M, HADZIGRAHIC E. Anti-cyclic citrullinated peptide antibody as a predictor of rheumathoid arthritis complications[J]. Med Arch, 2020, 74(3): 183-186. [8] SUR CHOWDHURY C, GIAGLIS S, WALKER U A, et al. Enhanced neutrophil extracellular trap generation in rheumatoid arthritis: analysis of underlying signal transduction pathways and potential diagnostic utility[J]. Arthritis Res Ther, 2014, 16(3): R122. [9] MURATA K, ITO H, HASHIMOTO M, et al. Fluctuation in anti-cyclic citrullinated protein antibody level predicts relapse from remission in rheumatoid arthritis: KURAMA cohort[J]. Arthritis Res Ther, 2020, 22(1): 268. [10] VITTECOQ O, POUPLIN S, KRZANOWSKA K, et al. Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients[J]. Rheumatology, 2003, 42(8): 939-946. [11] MUSTILA A, PAIMELA L, LEIRISALO-REPO M, et al. Antineutrophil cytoplasmic antibodies in patients with early rheumatoid arthritis: an early marker of progressive erosive disease[J]. Arthritis Rheum, 2000, 43(6): 1371-1377. [12] MUSTILA A, KORPELA M, MUSTONEN J, et al. Perinuclear antineutrophil cytoplasmic antibody in rheumatoid arthritis: a marker of severe disease with associated nephropathy[J]. Arthritis Rheum, 1997, 40(4): 710-717. [13] WÖSTMANN F, MÜLLER R U, GÖBEL H, et al. Case report: a peculiar glomerulopathy in a patient suffering from nephrotic syndrome[J]. BMC Nephrol, 2019, 20(1): 326. [14] RODRÍGUEZ E, LATZKE B, SIERRA M, et al. Antimyeloperoxidase and proteinase 3 antibodies for nephritis flare prediction in ANCA-associated-vasculitis[J]. Nephrol Dial Transplant,2022,37(4):697-704. |